Coenzyme Q10 Defects May Be Associated with a Deficiency of Q10-independent Mitochondrial Respiratory Chain Complexes

Overview

Journal Biol Res

Specialty Biology

Date 2016 Jan 9

PMID 26742794

Citations 10

Authors

Konstantina Fragaki

Annabelle Chaussenot

Jean-Francois Benoist

Samira Ait-El-Mkadem

Sylvie Bannwarth

Cecile Rouzier

Charlotte Cochaud

Veronique Paquis-Flucklinger

Affiliations

Soon will be listed here.

Abstract

Background: Coenzyme Q10 (CoQ10 or ubiquinone) deficiency can be due either to mutations in genes involved in CoQ10 biosynthesis pathway, or to mutations in genes unrelated to CoQ10 biosynthesis. CoQ10 defect is the only oxidative phosphorylation disorder that can be clinically improved after oral CoQ10 supplementation. Thus, early diagnosis, first evoked by mitochondrial respiratory chain (MRC) spectrophotometric analysis, then confirmed by direct measurement of CoQ10 levels, is of critical importance to prevent irreversible damage in organs such as the kidney and the central nervous system. It is widely reported that CoQ10 deficient patients present decreased quinone-dependent activities (segments I + III or G3P + III and II + III) while MRC activities of complexes I, II, III, IV and V are normal. We previously suggested that CoQ10 defect may be associated with a deficiency of CoQ10-independent MRC complexes. The aim of this study was to verify this hypothesis in order to improve the diagnosis of this disease.

Results: To determine whether CoQ10 defect could be associated with MRC deficiency, we quantified CoQ10 by LC-MSMS in a cohort of 18 patients presenting CoQ10-dependent deficiency associated with MRC defect. We found decreased levels of CoQ10 in eight patients out of 18 (45 %), thus confirming CoQ10 disease.

Conclusions: Our study shows that CoQ10 defect can be associated with MRC deficiency. This could be of major importance in clinical practice for the diagnosis of a disease that can be improved by CoQ10 supplementation.

Citing Articles

Role of abnormal energy metabolism in the progression of chronic kidney disease and drug intervention.

Liu X, Du H, Sun Y, Shao L Ren Fail. 2022; 44(1):790-805.

PMID: 35535500 PMC: 9103584. DOI: 10.1080/0886022X.2022.2072743.

Molecular targets of statins and their potential side effects: Not all the glitter is gold.

Patel K, Sehgal V, Kashfi K Eur J Pharmacol. 2022; 922:174906.

PMID: 35321818 PMC: 9007885. DOI: 10.1016/j.ejphar.2022.174906.

Epilepsia Partialis Continua a Clinical Feature of a Missense Variant in the ADCK3 Gene and Poor Response to Therapy.

Ashrafi M, Haghighi R, Badv R, Ghabeli H, Tavasoli A, Pourbakhtyaran E J Mol Neurosci. 2022; 72(5):1125-1132.

PMID: 35275351 PMC: 8914440. DOI: 10.1007/s12031-022-01993-0.

The Mutations and Clinical Variability in Maternally Inherited Diabetes and Deafness: An Analysis of 161 Patients.

Yang M, Xu L, Xu C, Cui Y, Jiang S, Dong J Front Endocrinol (Lausanne). 2021; 12:728043.

PMID: 34899594 PMC: 8654930. DOI: 10.3389/fendo.2021.728043.

Coenzyme Q at the Hinge of Health and Metabolic Diseases.

Hernandez-Camacho J, Garcia-Corzo L, Fernandez-Ayala D, Navas P, Lopez-Lluch G Antioxidants (Basel). 2021; 10(11).

PMID: 34829656 PMC: 8615162. DOI: 10.3390/antiox10111785.

References

Zierz S, Jahns G, Jerusalem F . Coenzyme Q in serum and muscle of 5 patients with Kearns-Sayre syndrome and 12 patients with ophthalmoplegia plus. J Neurol. 1989; 236(2):97-101. DOI: 10.1007/BF00314404. View

Zhang Y, Marcillat O, Giulivi C, Ernster L, Davies K . The oxidative inactivation of mitochondrial electron transport chain components and ATPase. J Biol Chem. 1990; 265(27):16330-6. View

Matsuoka T, Maeda H, Goto Y, Nonaka I . Muscle coenzyme Q10 in mitochondrial encephalomyopathies. Neuromuscul Disord. 1991; 1(6):443-7. DOI: 10.1016/0960-8966(91)90007-f. View

Rustin P, Chretien D, Bourgeron T, Gerard B, Rotig A, Saudubray J . Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta. 1994; 228(1):35-51. DOI: 10.1016/0009-8981(94)90055-8. View

Quinzii C, Kattah A, Naini A, Akman H, Mootha V, DiMauro S . Coenzyme Q deficiency and cerebellar ataxia associated with an aprataxin mutation. Neurology. 2005; 64(3):539-41. DOI: 10.1212/01.WNL.0000150588.75281.58. View

Lalani S, Vladutiu G, Plunkett K, Lotze T, Adesina A, Scaglia F . Isolated mitochondrial myopathy associated with muscle coenzyme Q10 deficiency. Arch Neurol. 2005; 62(2):317-20. DOI: 10.1001/archneur.62.2.317. View

Montero R, Artuch R, Briones P, Nascimento A, Garcia-Cazorla A, Vilaseca M . Muscle coenzyme Q10 concentrations in patients with probable and definite diagnosis of respiratory chain disorders. Biofactors. 2006; 25(1-4):109-15. DOI: 10.1002/biof.5520250112. View

Rotig A, Mollet J, Rio M, Munnich A . Infantile and pediatric quinone deficiency diseases. Mitochondrion. 2007; 7 Suppl:S112-21. DOI: 10.1016/j.mito.2007.02.008. View

Hsieh E, Gin P, Gulmezian M, Tran U, Saiki R, Marbois B . Saccharomyces cerevisiae Coq9 polypeptide is a subunit of the mitochondrial coenzyme Q biosynthetic complex. Arch Biochem Biophys. 2007; 463(1):19-26. PMC: 2080827. DOI: 10.1016/j.abb.2007.02.016. View

10.

Gempel K, Topaloglu H, Talim B, Schneiderat P, Schoser B, Hans V . The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene. Brain. 2007; 130(Pt 8):2037-44. PMC: 4345103. DOI: 10.1093/brain/awm054. View

11.

Geromel V, Darin N, Chretien D, Benit P, Delonlay P, Rotig A . Coenzyme Q(10) and idebenone in the therapy of respiratory chain diseases: rationale and comparative benefits. Mol Genet Metab. 2002; 77(1-2):21-30. DOI: 10.1016/s1096-7192(02)00145-2. View

12.

Desbats M, Lunardi G, Doimo M, Trevisson E, Salviati L . Genetic bases and clinical manifestations of coenzyme Q10 (CoQ 10) deficiency. J Inherit Metab Dis. 2014; 38(1):145-56. DOI: 10.1007/s10545-014-9749-9. View

13.

Baruteau J, Hargreaves I, Krywawych S, Chalasani A, Land J, Davison J . Successful reversal of propionic acidaemia associated cardiomyopathy: evidence for low myocardial coenzyme Q10 status and secondary mitochondrial dysfunction as an underlying pathophysiological mechanism. Mitochondrion. 2014; 17:150-6. DOI: 10.1016/j.mito.2014.07.001. View

14.

Garcia-Corzo L, Luna-Sanchez M, Doerrier C, Ortiz F, Escames G, Acuna-Castroviejo D . Ubiquinol-10 ameliorates mitochondrial encephalopathy associated with CoQ deficiency. Biochim Biophys Acta. 2014; 1842(7):893-901. DOI: 10.1016/j.bbadis.2014.02.008. View

15.

Bujan N, Arias A, Montero R, Garcia-Villoria J, Lissens W, Seneca S . Characterization of CoQ₁₀ biosynthesis in fibroblasts of patients with primary and secondary CoQ₁₀ deficiency. J Inherit Metab Dis. 2013; 37(1):53-62. DOI: 10.1007/s10545-013-9620-4. View

16.

Montero R, Grazina M, Lopez-Gallardo E, Montoya J, Briones P, Navarro-Sastre A . Coenzyme Q₁₀ deficiency in mitochondrial DNA depletion syndromes. Mitochondrion. 2013; 13(4):337-41. DOI: 10.1016/j.mito.2013.04.001. View

17.

Duberley K, Abramov A, Chalasani A, Heales S, Rahman S, Hargreaves I . Human neuronal coenzyme Q10 deficiency results in global loss of mitochondrial respiratory chain activity, increased mitochondrial oxidative stress and reversal of ATP synthase activity: implications for pathogenesis and treatment. J Inherit Metab Dis. 2012; 36(1):63-73. DOI: 10.1007/s10545-012-9511-0. View

18.

Trevisson E, DiMauro S, Navas P, Salviati L . Coenzyme Q deficiency in muscle. Curr Opin Neurol. 2011; 24(5):449-56. DOI: 10.1097/WCO.0b013e32834ab528. View

19.

Fragaki K, Cano A, Benoist J, Rigal O, Chaussenot A, Rouzier C . Fatal heart failure associated with CoQ10 and multiple OXPHOS deficiency in a child with propionic acidemia. Mitochondrion. 2011; 11(3):533-6. DOI: 10.1016/j.mito.2011.02.002. View

20.

Quinzii C, Lopez L, Gilkerson R, Dorado B, Coku J, Naini A . Reactive oxygen species, oxidative stress, and cell death correlate with level of CoQ10 deficiency. FASEB J. 2010; 24(10):3733-43. PMC: 2996902. DOI: 10.1096/fj.09-152728. View